Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation with Chemo/Radiotherapy in Solid Tumors
NCT04937842Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of peripheral blood stem cells in solid tumor (2 arms), sponsored by 307 Hospital of the People's Liberation Army. Primary endpoints: Treatment-Emergent Adverse Events at 1 month and Time of hematopoietic recovery at 1 month. Status: unknown.
02
Drugs
peripheral blood stem cells
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04937842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937842.